Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1993-10-25
1995-02-28
Henley, III, Raymond J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
514168, 552653, A61K 3159, A61K 31595
Patent
active
053937490
ABSTRACT:
A method of treating osteoporosis comprising the administration of an effective amount of 1.alpha.,25-dihydroxy-22(E)-dehydro-vitamin D.sub.3.
REFERENCES:
patent: 3833622 (1974-09-01), Babcock et al.
patent: 3901928 (1975-08-01), Hesse et al.
patent: 4255596 (1981-03-01), Wu et al.
patent: 4260549 (1981-04-01), DeLuca et al.
patent: 4267117 (1981-05-01), Salmond
patent: 4588528 (1986-05-01), DeLuca et al.
patent: 4588716 (1986-05-01), DeLuca et al.
patent: 4590184 (1986-05-01), Maeda et al.
patent: 4689180 (1987-08-01), DeLuca et al.
patent: 4719204 (1988-01-01), DeLuca et al.
patent: 4822609 (1989-04-01), Flora
patent: 4833125 (1989-05-01), Neer et al.
patent: 4997824 (1991-03-01), Popovtzer et al.
patent: 5001118 (1991-03-01), Maeda et al.
patent: 5053401 (1991-10-01), Matsumoto et al.
patent: 5104864 (1992-04-01), DeLuca et al.
J. Nutr. Biochem., vol. No. 1, Jan. 1993, pp. 49-57, Tai C. Chen et al, "An Evaluation of 1,25-Dihydroxyvitamin D.sub.3 Analogues on the Proliferation and Differentiation of Cultured Human Keratinocytes, Calcium Metabolism and the Differentiation of Human HL-60 Cells".
Arch. Toxicol, vol. 63, No. 5, 1989, pp. 394-400, Andreas Istler et al, "Effects of vitamin D Derivatives on Soft Tissue Calcification in Neonatal and Calcium Mobilization in Adult Rats".
DeLuca Hector F.
Schnoes Heinrich K.
Criares T. J.
Henley III Raymond J.
Wisconsin Alumni Research Foundation
LandOfFree
Method of treating osteoporosis with 1 .alpha.25-dihydroxy-22(E) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating osteoporosis with 1 .alpha.25-dihydroxy-22(E), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating osteoporosis with 1 .alpha.25-dihydroxy-22(E) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-848607